Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | NHS England |
| Main Category: | Services |
| Procurement Method: | Other - |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | £854,000 |
| Release Date: | 26 September 2023 |
| Application Deadline: | 10 July 2023 |
| Contract Start Date: | 27 September 2023 |
| Contract End Date: |
View Original Notice
Access the full notice on the official portal
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to
| Award value: | £854,000 |
| Award decision date: | 27 July 2023 |
| Award status: | Active |
The proposed 12-month programme will enable genotyping of blood groups by NHS BT in current patients (up to 17,800 patients) with either sickle cell or thalassemia. Additional information: Direct Award justified under Reg 32 as lack of competition due to technical reasons. NHSBT are the only organisation capable of delivering the scope of servcies
Published contracts in the last 12 months
2,046
total contracts
£179666.3m
total value
£251,986,446
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
10 July 2023
Closed
Estimated Value
£854,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| 27 July 2024 |
| Contract Duration: | 10 months |
| Procurement ID (OCID): | ocds-b5fd17-71fdc68f-174f-4e5a-8e29-cd209a979536 |
| Notice Reference: | 5ff577fe-a93a-4fc2-a40e-2607f3244365-683765 |